{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:39:12Z","timestamp":1795084752199,"version":"4.10.2"},"reference-count":38,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The emergence of the novel coronavirus in Wuhan, China, which causes severe respiratory tract infections in humans (COVID-19), has become a global health concern. Most coronaviruses infect animals but can evolve into strains that cross the species barrier and infect humans. At the present, there is no single specific vaccine or efficient antiviral therapy against COVID-19. Recently, we showed that intravenous immunoglobulin (IVIg) treatment reduces inflammation of intestinal epithelial cells and eliminates overgrowth of the opportunistic human fungal pathogen Candida albicans in the murine gut. Immunotherapy with IVIg could be employed to neutralize COVID-19. However, the efficacy of IVIg would be better if the immune IgG antibodies were collected from patients who have recovered from COVID-19 in the same city, or the surrounding area, in order to increase the chance of neutralizing the virus. These immune IgG antibodies will be specific against COVID-19 by boosting the immune response in newly infected patients. Different procedures may be used to remove or inactivate any possible pathogens from the plasma of recovered coronavirus patient derived immune IgG, including solvent\/detergent, 60 \u00b0C heat-treatment, and nanofiltration. Overall, immunotherapy with immune IgG antibodies combined with antiviral drugs may be an alternative treatment against COVID-19 until stronger options such as vaccines are available.<\/jats:p>","DOI":"10.3390\/ijms21072272","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T13:10:47Z","timestamp":1585141847000},"page":"2272","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-975X","authenticated-orcid":false,"given":"Samir","family":"Jawhara","sequence":"first","affiliation":[{"name":"CNRS, UMR 8576 - UGSF\u2014Unit\u00e9 de Glycobiologie Structurale et Fonctionnelle, INSERM U1285, F-59000 Lille, France"},{"name":"University of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Charlet, R., Sendid, B., Kaveri, S.V., Poulain, D., Bayry, J., and Jawhara, S. (2019). Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061473"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41426-018-0155-5","article-title":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats","volume":"7","author":"Hu","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chan, J.F., Yuan, S., Kok, K.H., To, K.K., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C.C., and Poon, R.W. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet.","DOI":"10.1016\/S0140-6736(20)30154-9"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, P., Chen, W., and Chen, J.P. (2019). Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica). Viruses, 11.","DOI":"10.3390\/v11110979"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., and Zhu, N. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet.","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., and Qian, Z. (2020). On the origin and continuing evolution of SARS-CoV-2. Natl. Sci. Rev.","DOI":"10.1093\/nsr\/nwaa036"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., Chen, H., Wang, D., Liu, N., and Liu, D. (2020). Characteristics of COVID-19 infection in Beijing. J. Infect.","DOI":"10.2139\/ssrn.3541134"},{"key":"ref_9","unstructured":"Baron, S. (1996). Coronaviruses. Medical Microbiology, Galveston (TX). Galveston, Tex: University of Texas Medical Branch at Galveston."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","first-page":"336A","article-title":"Coronavirus Associated Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Extracorporeal Membrane Oxygenation","volume":"146","author":"Rao","year":"2014","journal-title":"Crit. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357ra124","DOI":"10.1126\/scitranslmed.aag1153","article-title":"IVIG-mediated protection against necrotizing pneumonia caused by MRSA","volume":"8","author":"Diep","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/380909","article-title":"Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro","volume":"189","author":"Gauduchon","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","article-title":"In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases","volume":"12","author":"Krause","year":"2002","journal-title":"Transfus. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","article-title":"Intravenous immunoglobulins in immunodeficiencies: More than mere replacement therapy","volume":"164","author":"Kaveri","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_18","first-page":"e5849","article-title":"Treatments for Primary Immune Thrombocytopenia: A Review","volume":"11","author":"Samson","year":"2019","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tips.2004.04.002","article-title":"Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?","volume":"25","author":"Bayry","year":"2004","journal-title":"Trends Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chom.2016.10.018","article-title":"Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way","volume":"20","author":"Shopsin","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Lustig","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-006-9021-7","article-title":"Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases","volume":"26","author":"Ochs","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/ene.12080","article-title":"Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"20","author":"Markvardsen","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0b013e3181f735ce","article-title":"Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy","volume":"75","author":"Harbo","year":"2010","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1099\/vir.0.000079","article-title":"Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis","volume":"96","author":"Srivastava","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","article-title":"What is the contents of the magic draft IVIg?","volume":"7","author":"Seite","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/cmi.2014.117","article-title":"Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation","volume":"12","author":"Maddur","year":"2015","journal-title":"Cell Mol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barre syndrome patients","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0016-5085(98)70019-8","article-title":"Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn\u2019s disease","volume":"115","author":"Neut","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ibd.20246","article-title":"Dual-association of gnotobiotic IL-10-\/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis","volume":"13","author":"Kim","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/bmt.2015.212","article-title":"Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus","volume":"51","author":"Boukhvalova","year":"2016","journal-title":"Bone Marrow Transpl."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fimmu.2015.00431","article-title":"Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses","volume":"6","author":"Orange","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1423-0410.2007.01016.x","article-title":"A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: Virus and prion reduction capacity","volume":"94","author":"Poelsler","year":"2008","journal-title":"Vox Sang."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.biologicals.2010.02.008","article-title":"Viral safety characteristics of Flebogamma DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin","volume":"38","author":"Caballero","year":"2010","journal-title":"Biologicals"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biologicals.2012.04.007","article-title":"Virus reduction in an intravenous immunoglobulin by solvent\/detergent treatment, ion-exchange chromatography and terminal low pH incubation","volume":"40","author":"Roberts","year":"2012","journal-title":"Biologicals"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1423-0410.2005.00710.x","article-title":"Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product","volume":"90","author":"Terpstra","year":"2006","journal-title":"Vox Sang."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/7\/2272\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:11:32Z","timestamp":1760173892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/7\/2272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21072272"],"URL":"https:\/\/doi.org\/10.3390\/ijms21072272","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]}}}